FDA Investigator Carolina D Vasquez
Carolina D Vasquez has inspections in 2 countries as of 22 Sep 2023. Carolina D Vasquez has collaborated with a combined 1298 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
11
Last Inspection Date:
22 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
China
Co-Investigator(s):
Arsen Karapetyan,
Azza Talaat,
Binh T Nguyen,
Brien C Fox,
Carla J Lundi,
Carr Sharpe,
Caryn M Mcnab,
Chelsea N Sealey,
Christine R Casey,
Christopher R Czajka,
Crystal Monroy,
Darren S Brown,
Deborah A Greco,
Diane R Weidley,
Dongping Dai, PhD,
Donna Mwilliams Hill,
Dr. Robert C Horan, MD,
Dr. S Nar Ali, PhD,
Esther B Gamallo Herrera,
Farhana Khan,
Felix Maldonado,
Francis A Guidry,
Gene D Arcy,
Ginger M Sykes,
Gwyn G Dickinson,
Haroon Vohra (NMI),
Heidy C Perales,
James B Arnett,
James M Timper Jr,
Jeffrey P Raimondi,
Jose R Hernandez,
Juanita Banuelos,
Katherine E Jacobitz,
Kathryn M Megen,
Kathryn M Mogen,
Kathy Chiu,
Kathy Kuo,
Kelley,
Kenneth H Williams,
Kham Phommachanh,
Kim Lthomas Cruse,
Kim Thomas Chase,
Kristen E Szenderski,
Kristin M Abaonza,
Langer,
Larisa E Pavlick,
Larry K Austin,
Laura B Kennedy,
Liming Zhang,
Linda M Cheny,
Linda Thai,
LT Richard A Lyght,
Lucas B Leake,
Marcus F Yambot,
Matthew A Johnson,
Michael D Garcia,
Nicholas L Hunt,
Ricki A Chase,
Rumany C Penn, PharmD,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Sean P Desbrow,
State Agency,
Sumit Sen,
Syed N Ali,
Taichun Qin, PhD,
Tamala P Bogan,
Tamala P Magee,
Terri L Dodds,
Tracey L Harris,
Uttaniti Limchumroon (Tom),
Vashti E Bocker,
Virgilio F Pacio, CSO,
Yumi J Hiramine,
Zachary A Bogorad
Carolina D Vasquez's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2021 | FDA 483 | Swabplus, L.P. - Form 483, 2021-10-15 |
September, 2022 | FDA 483 | TG Labs, Inc. - Form 483, 2022-09-29 |
May, 2022 | FDA 483 | MICRO CONNECTION ENTERPRISES, INC., THE - Form 483, 2022-05-13 |
December, 2022 | FDA 483 | Orly International - Form 483, 2022-12-20 |
August, 2021 | FDA 483 | Product Packaging West, Inc. - Form 483, 2021-08-27 |
November, 2021 | EIR | Polypeptide Laboratories Inc - EIR, 2021-11-19 |
November, 2023 | FDA 483 | Westwood Laboratories, LLC. - Form 483, 2023-11-20 |
March, 2022 | FDA 483 | USANA Health Sciences, Inc. - Form 483, 2022-03-29 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more